Drugs / Piboserod
last change Jun 2009 re-read 3 minutes ago

Piboserod

Developed for
congestive heart failure
Investigated by
Bio-Medisinsk Innovasjon · Smerud Medical Research International AS

Trials 1

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00421746 Jan 2006 → Jul 2007 congestive heart failure Bio-Medisinsk Innovasjon Completed Met primary

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Piboserod ClinicalTrials.gov intervention name — accepted as the source's own label NCT00421746 ↗
Action Inhibit “piboserod, a potent, selective, 5-HT(4) serotonin receptor antagonist” PMID 19567409 ↗ Jun 2009